Literature DB >> 26812027

Individual and combined in vitro (anti)androgenic effects of certain food additives and cosmetic preservatives.

Anca Pop1, Tudor Drugan2, Arno C Gutleb3, Diana Lupu4, Julien Cherfan5, Felicia Loghin6, Béla Kiss7.   

Abstract

The individual and combined (binary mixtures) (anti)androgenic effect of butylparaben (BuPB), butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and propyl gallate (PG) was evaluated using the MDA-kb2 cell line. Exposing these cells to AR agonists results in the expression of the reporter gene (encoding for luciferase) and luminescence can be measured in order to monitor the activity of the reporter protein. In case of the evaluation of the anti-androgenic effect, the individual test compounds or binary mixtures were tested in the presence of a fixed concentration of a strong AR agonist (1000 pM 5-alpha-dihydrotestosterone; DHT). Cell viability was assessed using a resazurin based assay. For PG, this is the first report in the literature concerning its (anti)androgenic activity. In case of both individual and mixture testing none of the compounds or binary combinations showed androgenic activity. When tested in the presence of DHT, BuPB, BHA and BHT proved to be weak anti-androgens and this was confirmed during the evaluation of binary mixtures (BuPB+BHA, BuPB+BHT and BHA+BHT). Besides performing the in vitro testing of the binary combinations, two mathematical models (dose addition and response addition) were evaluated in terms of accuracy of prediction of the anti-androgenic effect of the selected binary mixtures. The dose addition model guaranteed a good correlation between the experimental and predicted data. However, no estimation was possible in case of mixtures containing PG, due to the lack of effect of the compound in case of the individual testing.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anti-androgen; Endocrine disruptor; In vitro; Luciferase; Mixture

Mesh:

Substances:

Year:  2016        PMID: 26812027     DOI: 10.1016/j.tiv.2016.01.012

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

1.  Determining the endocrine disruption potential of industrial chemicals using an integrative approach: Public databases, in vitro exposure, and modeling receptor interactions.

Authors:  Olubusayo Alofe; Edwina Kisanga; Salmaan H Inayat-Hussain; Masao Fukumura; Rolando Garcia-Milian; Lalith Perera; Vasilis Vasiliou; Shannon Whirledge
Journal:  Environ Int       Date:  2019-07-13       Impact factor: 9.621

2.  In Vitro Evaluation of Biological Activities of Canes and Pomace Extracts from Several Varieties of Vitis vinifera L. for Inclusion in Freeze-Drying Mouthwashes.

Authors:  Anca Pop; Catalina Bogdan; Ionel Fizesan; Sonia Iurian; Rahela Carpa; Cecilia Bacali; Laurian Vlase; Daniela Benedec; Mirela L Moldovan
Journal:  Antioxidants (Basel)       Date:  2022-01-24

3.  Safety and efficacy of a feed additive consisting of butylated hydroxytoluene (BHT) for all animal species (Katyon Technologies Limited).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Birgit Dusemund; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Antonio Finizio; Ivana Teodorovic; Gabriele Aquilina; Georges Bories; Jurgen Gropp; Carlo Nebbia; Matteo Innocenti
Journal:  EFSA J       Date:  2022-05-10

4.  An in silico approach to study the interaction of BHA with selected steroid hormone receptors and investigating it's agonistic and antagonistic properties.

Authors:  Subin Balachandran; R N Binitha
Journal:  In Silico Pharmacol       Date:  2021-01-28

5.  Safety and efficacy of a feed additive consisting of butylated hydroxytoluene (BHT) for all animal species (Lanxess Deutschland GmbH).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Birgit Dusemund; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Antonio Finizio; Ivana Teodorovic; Gabriele Aquilina; Georges Bories; Jurgen Gropp; Carlo Nebbia; Matteo Innocenti
Journal:  EFSA J       Date:  2022-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.